Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.

Published September 28, 2026 · Category: Finance

Overview

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Source

Originally published at www.marketwatch.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.